• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INOGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INOGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G140
Device Problems High impedance (1291); Material Integrity Problem (2978)
Patient Problems No Code Available (3191); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/11/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4).At this time, the product has not been returned.If the product is returned, analysis will be performed and this report would be updated.
 
Event Description
It was reported during a revision procedure that this cardiac resynchronization therapy defibrillator (crt-d) device exhibited high out of range pacing impedance measurements of 3,000 ohms.A different device was implanted.Testing of the right ventricular (rv) lead with the pacing system analyzer (psa) confirmed this was not a lead issue, and more than likely a header issue.No adverse patient effects were reported.The device is expected to be returned for analysis.
 
Event Description
It was reported during a revision procedure that this cardiac resynchronization therapy defibrillator (crt-d) device exhibited high out of range pacing impedance measurements of 3,000 ohms.A different device was implanted.Testing of the right ventricular (rv) lead with the pacing system analyzer (psa) confirming this was not a lead issue, and more than likely a header issue.No adverse patient effects were reported.The device is expected to be returned for analysis.
 
Manufacturer Narrative
The returned device was inspected and analyzed upon receipt at our post market quality assurance laboratory.Visual examination of the device header and case noted no anomalies.Pin gauge testing, designed to verify proper port dimensions, was completed.Each port measured as expected.Pacing and sensing functions were tested and the device was verified to operate as expected.Analysis did not identify any device characteristics that would have caused or contributed to the report clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INOGEN CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key10681591
MDR Text Key211453439
Report Number2124215-2020-20716
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/14/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/04/2022
Device Model NumberG140
Device Catalogue NumberG140
Device Lot Number498977
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/15/2020
Date Manufacturer Received03/29/2021
Patient Sequence Number1
Patient Outcome(s) Other;
-
-